Biosimilars are an opportunity to help reduce the burden of rising treatment costs.
Diversity drives innovation, which in turn drives change and progress.
Sandoz announced a commitment of $10 million USD in medicines to Americares.
Novartis announces fourth quarter and full year financial results for 2019 at 07:00 CET on January 29, 2020.
See our product listing, including: NDCs, Size, Dosage Forms and more.
This site is intended for a US audience